The India biosimilar market was valued at INR 4.37 billion in 2024 and is projected to reach INR 16.49 billion by 2034, growing at a CAGR of 14.20%. Market growth is driven by the rising prevalence of chronic diseases, expanding healthcare access, and increasing demand for cost-effective biologic alternatives. https://www.expertmarketresearch.com/reports/india-biosimilar-market